Nonalcoholic fatty liver disease (NAFLD) is seen worldwide and is the most common liver disorder in Western industrialized countries. Non-alcoholic fatty liver disease (NAFLD) can occur after liver transplantation (LT), as recurrence or de novo hepatic steatosis (HS). NAFL has considered when liver biopsy shows steatosis alone, steatosis with lobular or portal inflammation,